Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 4/2015

01-05-2015 | Original Paper

Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life

Authors: Jacinto Mosquera Nogueira, Eva Rodríguez-Míguez

Published in: The European Journal of Health Economics | Issue 4/2015

Login to get access

Abstract

Alcohol dependence not only reduces life expectancy, but also causes considerable loss of quality of life of the dependents of and persons around those with alcohol dependence. This article presents new evidence on the impact of alcohol dependence on health-related quality of life in Spain. Three samples were recruited: 150 alcoholics and 64 family members of alcoholics, with both samples taken from an alcoholism treatment unit, and 600 persons from the general population. We used the short form 6D, a preference-based generic instrument, applying the utility scores estimated for Spain. It was found that the annual mean loss of quality-adjusted life years associated with alcohol dependence was 0.144 and 0.083 for the alcoholics and their close family members, respectively. This impact becomes more notable after controlling for socio economic variables and was higher than that estimated in similar studies. Possible explanations for these differences are discussed. The results from this work can be applied to economic evaluation studies measuring benefits from policies targeted at reducing the prevalence of alcohol dependence.
Literature
1.
2.
3.
Campos, J., Roca, L., Gude, F., González-Quintela, A.: Long-term mortality of patients admitted to the hospital with alcohol withdrawal syndrome. Alcohol Clin Exp Res 35, 1180–1186 (2011)CrossRefPubMed
4.
John, U., Rumpf, H.J., Bischof, G., Hapke, U., Hanke, M., Meyer, C.: Excess mortality of alcohol-dependent individuals after 14 years and mortality predictors based on treatment participation and severity of alcohol dependence. Alcohol Clin Exp Res 37(1), 156–163 (2013)CrossRefPubMed
5.
Markkula, N., Harkanen, T., Perala, J., Partti, K., Pena, S., Koskinen, S., Lonnqvist, J., Suvisaari, J., Saarni, S.I.: Mortality in people with depressive, anxiety and alcohol use disorders in Finland. Br J Psychiatry 200, 143–149 (2012)CrossRefPubMed
6.
7.
Daeppen, J.B., Krieg, M.A., Burnand, B., Yersin, B.: MOS-SF-36 in evaluating health-related quality of life in alcohol-dependent patients. Am J Drug Alcohol Abuse 24(4), 685–694 (1998)CrossRefPubMed
8.
Kraemer, K., Maisto, S., Conigliaro, J., NcNeil, M., Gordon, A., Kelley, M.: Decreased alcohol consumption in outpatient drinkers is associated with improved quality of life and fewer alcohol-related consequences. J Gen Intern Med 17, 382–386 (2002)CrossRefPubMedCentralPubMed
9.
Lahmek, P., Berlin, I., Michel, L., Berghout, C., Meunier, N., Aubin, H.J.: Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme. Int J Med Sci 6(4), 160–167 (2009)CrossRefPubMedCentralPubMed
10.
Pettinati, H., Gastfriend, D., Dong, Q., Kranzler, H., O’Malley, S.: Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients. Alcohol Clin Exp Res 33(2), 350–356 (2009)CrossRefPubMedCentralPubMed
11.
Strangesc, S., Notaro, J., Freudenheim, J.L., Calogero, R.M., Muti, P., Farinaro, E., Russell, M., Nochajski, T.H., Trevisan, M.: Alcohol drinking pattern and subjective health in a population-based study. Addiction 101(9), 1265–1276 (2006)CrossRef
12.
Peltzer, K., Pengpid, S.: Alcohol use and health-related quality of life among hospital outpatients in South Africa. Alcohol Alcohol 47(3), 291–295 (2012)CrossRefPubMed
13.
Malet, L., Llorca, P., Beringuier, B., Lehert, P., Falissard, B.: AlQol 9 for measuring quality of life in alcohol dependence. Alcohol Alcohol 41(2), 181–187 (2006)CrossRefPubMed
14.
Drummond, M., Sculpher, M., Torrance, G., O’Brien, B., Stoddart, G.: Methods for the economic evaluation of health care programmes. Oxford University Press, New York (2005)
15.
Taylor, R.S., Drummond, M., Salkeld, G., Sullivan, S.D.: Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. Br Med J 329(7472), 972–975 (2004)CrossRef
16.
17.
Popovici, I., French, M.T., McKay, J.R.: Economic evaluation of continuing care interventions in the treatment of substance abuse: recommendations for future research. Eval Rev 32, 547–568 (2008)CrossRefPubMed
18.
Schori, M.: Valuation of drug abuse: a review of current methodologies and implications for policy making. Res Soc Work Pract 21(4), 421–431 (2011)CrossRef
19.
20.
Rawlins, M.D., Culyer, A.J.: National Institute for Clinical Excellence and its value judgments. Br Med J 329, 224–227 (2004)CrossRef
21.
Kraemer, K., Roberts, M., Horton, N., Palfai, T., Samet, J., Freedner, N., Tibbetts, N., Saitz, R.: Health utility ratings for a spectrum of alcohol-related health states. Med Care 43(6), 541–550 (2005)CrossRefPubMed
22.
Sanderson, K., Andrews, G., Corry, J., Lapsley, H.: Using the effect size to model change in preference values from descriptive health status. Qual Life Res 13, 1255–1264 (2004)CrossRefPubMed
23.
Stouthard, M.E., Essink-Bot, M.L., Bonsel, G.L., Barendregt, J.J., Kramers, P.G., Water, H.P., Gunning-Schepers, L.J., Maas, P.J.: Disability weights for diseases in the Netherlands. Erasmus University, Rotterdam (1997)
24.
Pyne, J., Tripathi, S., French, M., McCollister, K., Rapp, R., Booth, B.: Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction 106(3), 507–515 (2011)CrossRefPubMedCentralPubMed
25.
Walters, D., Connor, J., Feeney, G., Young, R.: The cost effectiveness of naltrexone added to cognitive–behavioral therapy in the treatment of alcohol dependence. J Addict Dis 28(2), 137–144 (2009)CrossRefPubMed
26.
Parrott, S., Godfrey, C., Heather, N., Clark, J., Ryan, T.: Cost and outcome analysis of two alcohol detoxification services. Alcohol Alcohol 41, 84–91 (2006)CrossRefPubMed
27.
UK Alcohol Treatment Trial Research Team: Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). Br Med J 331, 544–548 (2005)CrossRef
28.
Saarni, S., Suvisaari, J., Sintonen, H., Pirkola, S., Koskinen, S., Aromaa, A., Lonnqvist, J.: Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 190, 326–332 (2007)CrossRefPubMed
29.
Maheswaran, H., Petrou, S., Rees, K., Stranges, S.: Estimating EQ-5D utility values for major health behavioural risk factors in England. J Epidemiol Community Health 67, 172–180 (2013)CrossRefPubMed
30.
Petrie, D., Doran, C., Shakeshaft, A., Sanson-Fisher, R.: The relationship between alcohol consumption and self-reported health status using the EQ5D. Soc Sci Med 67, 1717–1726 (2008)CrossRefPubMed
31.
Laslett, A.M., Catalano, P., Chikritzhs, Y., Dale, C., Doran, C., Ferris, J., Jainullabudeen, T., Livingston, M., Matthews, S., Mugavin, J., Room, R., Schlotterlein, M., Wilkinson, C.: The range and magnitude of alcohol’s harm to others. AER Centre for Alcohol Policy Research, Turning Point Alcohol and Drug Centre Health, Fitzroy (2010)
32.
Nutt, D., King, L., Phillips, L.: Drugs harms in the UK: a multicriteria decision analysis. Lancet 376, 1558–1565 (2010)CrossRefPubMed
33.
Jarl, J., Johansson, P., Eriksson, A., Eriksson, M., Gerdtham, U., Hemström, O., Hradilova, K., Lenke, L., Ramstedt, M., Room, R.: The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. Eur J Health Econ 9, 351–360 (2008)CrossRefPubMed
34.
Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J Health Econ 21(2), 271–292 (2002)CrossRefPubMed
35.
Brazier, J., Roberts, J.: The estimation of a preference-based measure of health from the SF-12. Med Care 42(9), 851–859 (2004)CrossRefPubMed
36.
Ware, J.E., Snow, K.K., Kolinski, M., Gandeck, B.: SF-36 health survey manual and interpretation guide. N.Engl Med Cent, Boston (1993)
37.
Bharmal, M., Thomas, J.: Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9(4), 262–271 (2006)CrossRefPubMed
38.
Longworth, L., Bryan, S.: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 12(12), 1061–1067 (2003)CrossRefPubMed
39.
Tsuchiya, A., Brazier, J., Roberts, J.: Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ 25, 334–346 (2006)CrossRefPubMed
40.
Abellán, J.M., Sánchez, F.I., Martínez, J.E., Méndez, I.: Lowering the “floor” of the SF-6D scoring algorithm using a lottery equivalent method. Health Econ 21(11), 1271–1285 (2012)CrossRef
41.
McCord, M., de Neufville, R.: Lottery equivalents: reduction of the certainty effect problem in utility assessment. Manage Sci 32, 56–60 (1986)CrossRef
42.
McBee, M.: Modeling Outcomes With Floor or Ceiling Effects: an Introduction to the Tobit Model. Gifted Child Q 54(4), 314–320 (2010)CrossRef
43.
Walters, S.J., Brazier, J.: Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14(6), 1523–1532 (2005)CrossRefPubMed
44.
American Psychiatric Association: Diagnostic and statistical manual of mental disorders,  4th edn. Author, Washington, DC (2000)
45.
Babor, T.F., Biddle-Higgins, J.C., Saunders, J.B., Monteiro, M.G.: AUDIT: The alcohol use disorder identification test: guidelines for use in primary health care. World Health Organization, Geneva (2001)
46.
Wittchen, H.U., Lachner, G., Wunderlich, U., Pfister, H.: Test–retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33, 568–578 (1998)CrossRefPubMed
47.
Fergusson, D., Boden, J.M., Horwood, L.J.: Tests of causal links between alcohol abuse or dependence and major depression. Arch Gen Psychiatry 66(3), 260–266 (2009)CrossRefPubMed
48.
Mentzakis, E., Suhrcke, M., Roberts, B., Murphy, A., McKee, M.: Estimating the causal effect of alcohol consumption on well-being for a cross-section of 9 former Soviet Union countries. Soc Sci Med 89, 1–7 (2013)CrossRefPubMed
49.
Rehm, J., Rehm, M., Shield, K., Gmel, G., Gual, A.: Alcohol consumption, alcohol dependence and related harms in Spain, and the effect of treatment-based interventions on alcohol dependence. Adicciones 25(1), 11–18 (2013)PubMed
Metadata
Title
Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life
Authors
Jacinto Mosquera Nogueira
Eva Rodríguez-Míguez
Publication date
01-05-2015
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 4/2015
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0627-z

Other articles of this Issue 4/2015

The European Journal of Health Economics 4/2015 Go to the issue

Original Paper

The impact of office-based care on hospitalizations for ambulatory care sensitive conditions

Original Paper

Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter?

Commentary

Comment on: “Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care”

Editorial

Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?

Original Paper

Does prospective payment increase hospital (in)efficiency? Evidence from the Swiss hospital sector

Original Paper

Gender differences in French GPs’ activity: the contribution of quantile regressions